Geode Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124M | Buy |
|
|||||
|
2025
Q1 | $143M | Buy |
|
|||||
|
2024
Q4 | $135M | Sell |
|
|||||
|
2024
Q3 | $124M | Sell |
|
|||||
|
2024
Q2 | $119M | Buy |
|
|||||
|
2024
Q1 | $133M | Buy |
|
|||||
|
2023
Q4 | $129M | Buy |
|
|||||
|
2023
Q3 | $131M | Buy |
|
|||||
|
2023
Q2 | $124M | Buy |
|
|||||
|
2023
Q1 | $139M | Buy |
|
|||||
|
2022
Q4 | $149M | Buy |
|
|||||
|
2022
Q3 | $117M | Sell |
|
|||||
|
2022
Q2 | $139M | Sell |
|
|||||
|
2022
Q1 | $139M | Sell |
|
|||||
|
2021
Q4 | $124M | Buy |
|
|||||
|
2021
Q3 | $119M | Sell |
|
|||||
|
2021
Q2 | $177M | Buy |
|
|||||
|
2021
Q1 | $149M | Buy |
|
|||||
|
2020
Q4 | $127M | Sell |
|
|||||
|
2020
Q3 | $119M | Sell |
|
|||||
|
2020
Q2 | $94.9M | Sell |
|
|||||
|
2020
Q1 | $86.4M | Buy |
|
|||||
|
2019
Q4 | $128M | Buy |
|
|||||
|
2019
Q3 | $101M | Buy |
|
|||||
|
2019
Q2 | $112M | Buy |
|
|||||
|
2019
Q1 | $102M | Buy |
|
|||||
|
2018
Q4 | $78.3M | Buy |
|
|||||
|
2018
Q3 | $95.8M | Buy |
|
|||||
|
2018
Q2 | $95.4M | Buy |
|
|||||
|
2018
Q1 | $66.9M | Buy |
|
|||||
|
2017
Q4 | $56.5M | Buy |
|
|||||
|
2017
Q3 | $59.9M | Buy |
|
|||||
|
2017
Q2 | $62.2M | Buy |
|
|||||
|
2017
Q1 | $57M | Buy |
|
|||||
|
2016
Q4 | $41.2M | Buy |
|
|||||
|
2016
Q3 | $43.9M | Buy |
|
|||||
|
2016
Q2 | $50.6M | Sell |
|
|||||
|
2016
Q1 | $51.9K | Buy |
|
|||||
|
2015
Q4 | $51.8M | Buy |
|
|||||
|
2015
Q3 | $47.6M | Buy |
|
|||||
|
2015
Q2 | $62.1M | Buy |
|
|||||
|
2015
Q1 | $58.8M | Buy |
|
|||||
|
2014
Q4 | $52.5M | Buy |
|
|||||
|
2014
Q3 | $49.9M | Buy |
|
|||||
|
2014
Q2 | $40.8M | Sell |
|
|||||
|
2014
Q1 | $39.7M | Buy |
|
|||||
|
2013
Q4 | $35.4M | Buy |
|
|||||
|
2013
Q3 | $21.7M | Buy |
|
|||||
|
2013
Q2 | $15.2M | Buy |
|